| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002055557A3 Human proteins and nucleic acids encoding same |
| 03/25/2004 | WO2002051433A3 Use of artemin, a member of the gdnf ligand family for preparing a neuroprotective medicament |
| 03/25/2004 | WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 03/25/2004 | WO2002042439A3 Aggrecanase adamts9 |
| 03/25/2004 | WO2002017899A3 Regulation of angiogenesis via modulation of edg receptor mediated signal transduction comprising sphingosine-1-phosphate administration |
| 03/25/2004 | US20040060077 Using dietary restriction to lower serum insulin levels and function as tool in treatment and prevention of alzheimer's diseases |
| 03/25/2004 | US20040059089 Comprises receptor protein for controlling gene expression in transgenic cells; for diagnosis, prevention and treatment of heart, tumor and urogenital disorders |
| 03/25/2004 | US20040059088 Short amphipathic peptides with activity against bacteria and intracellular pathogens |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040058984 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 03/25/2004 | US20040058981 Administering free radical generators such as artemisinim, arteflene |
| 03/25/2004 | US20040058976 Ophthalmic compositions for treating ocular hypertension |
| 03/25/2004 | US20040058900 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 03/25/2004 | US20040058886 Short interfering RNAs having a hairpin structure containing a non-nucleotide loop |
| 03/25/2004 | US20040058884 Detecting diseases by Selex method; anticancer agents |
| 03/25/2004 | US20040058877 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
| 03/25/2004 | US20040058876 Secondary binding site of dipeptidyl peptidase IV (DP IV) |
| 03/25/2004 | US20040058875 Prevent cytokine biosynthesis; topical applying to eye |
| 03/25/2004 | US20040058874 Synthetic peptide and uses for same |
| 03/25/2004 | US20040058873 Method for treating or preventing Alzheimer's disease |
| 03/25/2004 | US20040058871 Purification a supernatant; electrophoresis; antiproliferative agents; antiinflammatory agent |
| 03/25/2004 | US20040058870 Reduce blood glucose concentration; antidiabetic agent; respiratory system disorders |
| 03/25/2004 | US20040058869 Methods and reagents for modulating cholesterol levels |
| 03/25/2004 | US20040058867 Management of the consequences of fetal programming |
| 03/25/2004 | US20040058866 Method for preparing tryptophan rich peptides |
| 03/25/2004 | US20040058865 Homing peptide multimers, their preparation and uses |
| 03/25/2004 | US20040058864 Cyclic peptides; three-dimensional structures; screening; anticancer agents; angiogenesis inhibitors; drug delivery |
| 03/25/2004 | US20040058862 Novel polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058859 Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof |
| 03/25/2004 | US20040058857 Mixture of glucocorticoids and prostate specific antigen, or complex thereof; anticancer agents |
| 03/25/2004 | US20040058856 Fusion protein; efficient transduction; penetration of cell membrane |
| 03/25/2004 | US20040058850 Using caspase inhibitor; antiinflammatory agents |
| 03/25/2004 | US20040058849 Fibroblast growth factor receptors and methods for their use |
| 03/25/2004 | US20040058446 Transfecting cells with nucleic acids; gene therapy |
| 03/25/2004 | US20040058443 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 03/25/2004 | US20040058425 Crystal structure |
| 03/25/2004 | US20040058424 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058416 Human trk receptors and neurotrophic factor inhibitors |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058413 Method for the production of vitamin k-dependent proteins |
| 03/25/2004 | US20040058411 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058400 Multivalent and multispecific binding proteins, their manufacture and use |
| 03/25/2004 | US20040058398 Pancreatic progenitor cells and methods for isolating the same |
| 03/25/2004 | US20040058393 Monoclonal antibodies which can transduce agonist signal into cells for treatment and prevention of cancer, inflammation, hormone and blood disorders |
| 03/25/2004 | US20040058379 Tumor suppressor gene, p47Ing3 |
| 03/25/2004 | US20040058377 Novel G-protein coupled receptors and uses therefor |
| 03/25/2004 | US20040058371 Novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 03/25/2004 | US20040058367 Comprises interleukin 1b converting enzyme inhibitor for diagnosis, prevention and treatment of viral, nervous system, ischemic and graft-versus-host diseases |
| 03/25/2004 | US20040058361 Antibacterial treatments |
| 03/25/2004 | US20040058358 Lipid metabolism transcription factor |
| 03/25/2004 | US20040058353 Comprises nucleotide sequences coding transport proteins for diagnosis and treatment of pain, psychotic, eating and nervous system disorders |
| 03/25/2004 | US20040058350 Regulation of human secretin receptor-like gpcr |
| 03/25/2004 | US20040058347 Novel proteins and nucleic acids encoding same |
| 03/25/2004 | US20040058342 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 03/25/2004 | US20040058338 Novel proteins and nucleic acids encoding same |
| 03/25/2004 | US20040058326 Identification and use of molecules implicated in pain |
| 03/25/2004 | US20040058318 Transcripton factor comprising tyrosine kinase and interferon binding domains for diagnosis and treatment of autoimmune and immune response disorders; imunosuppressants |
| 03/25/2004 | US20040058313 Using gabapentim to relieve external pressure and improve glaucoma treatments; neuroprotectants and eye surgery; neurotoxins and vision defects |
| 03/25/2004 | US20040058309 Blood composition for use in bioartificial liver for in vitro detoxification and treatment of hepatocyte disfunction |
| 03/25/2004 | US20040058049 Increase the uptake of minerals |
| 03/25/2004 | US20040058025 Digestive/laxative compositions |
| 03/25/2004 | US20040058007 Such as proteins or polypeptides via anti-solvent under supercritical conditions; water solubility |
| 03/25/2004 | US20040057996 Initial release of the bioactive substance is suppressed; matrix containing a bioactive substance and a cationic substance (e.g. benzalkonium chloride or lysine) and/or a polyol such as polyethylene glycol |
| 03/25/2004 | US20040057959 Recombitope peptides |
| 03/25/2004 | US20040057954 Tumor necrosis factor antagonists and their use in endometriosis |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | US20040057951 Co-administration of a thrombolytic and an anti-CD18 antibody in stroke |
| 03/25/2004 | US20040057950 Overexpression of which can lead to tumorigenesis; useful in treatment of tumors of breast, lung, colon, kidney, bladder, head and neck, ovary, prostate, and brain |
| 03/25/2004 | US20040057948 For use as an anticancer agent and an immunosuppressive agent |
| 03/25/2004 | US20040057947 For therapy of ischaemic conditions |
| 03/25/2004 | US20040057946 Forming a solution of protein encapsulated, insoluble gas-filled microbubbles conjugated to biological agent; administering solution to animal; so that protein directs microbubble-conjugated agent to sites of bioprocessing |
| 03/25/2004 | US20040057945 For therapy of tumor, wart, hyperproliferative cellular condition |
| 03/25/2004 | US20040057944 For therapy and/or prophylaxis of maldigestion, especially maldigestion caused by pancreatic insufficiency, in humans or other mammals |
| 03/25/2004 | US20040057941 Delivering into cells of the subject an effective amount of a nucleic acid expression construct that encodes a growth-hormone-releasing-hormone ("GHRH") or functional biological equivalent thereof for therapy of anemia |
| 03/25/2004 | US20040057936 Tissue is soaked in a cold stabilizing solution; soaking in polyglycol, salt, hydrogen peroxide, and phosphate buffer; soaking in alcohol soaling in solution of an anti-inflammatory agent, an anti-thrombic agent, alcohol, and water |
| 03/25/2004 | US20040057929 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells |
| 03/25/2004 | US20040057928 Use of IL-6R/IL-6 chimera, a mutein, isoform, fused protein, functional derivative, active fraction or circularly permutated derivative or a salt thereof, for manufacture of medicament for therapy and/or prophylaxis |
| 03/25/2004 | US20040057927 Formulations for IL-11 |
| 03/25/2004 | US20040057926 Administering inhibitor of arginase I, an inhibitor of a cationic amino acid transporter Y+ receptor or a liposomal formulation of arginine or an arginine provider to a mammal wherein an immune response in mammal is increased |
| 03/25/2004 | US20040057925 Methods of enhancing bioactivity of chemokines |
| 03/25/2004 | US20040055609 Treatment of hepatitis C using hyperthermia |
| 03/25/2004 | DE10306085A1 New nucleic acid encoding splice variant of protein kinase A anchor protein, useful e.g. for identifying agents for treating diabetes or hypertension, also new polypeptide |
| 03/25/2004 | DE10242319A1 New double-stranded oligonucleotides, useful for treating e.g. cardiovascular disease and arthritis, are decoys that lift inhibition of expression of endothelial nitric oxide synthase |
| 03/25/2004 | DE10242016A1 Identifying blood-brain barrier protein, useful e.g. as drug transporter and for treatment or diagnosis, by subtractive hybridization using cDNA from brain capillary cells |
| 03/25/2004 | CA2799437A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2499214A1 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/25/2004 | CA2499075A1 Production of bispecific molecules using polyethylene glycol linkers |
| 03/25/2004 | CA2499014A1 Lactoferrin compositions and methods of wound treatment |
| 03/25/2004 | CA2498931A1 Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same |
| 03/25/2004 | CA2498784A1 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | CA2498777A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | CA2498771A1 2',5'-oligoadenylate phosphodiesterase |
| 03/25/2004 | CA2498757A1 Proline ester and preparation containing the same for percutaneous administration |
| 03/25/2004 | CA2498751A1 Nell-1 enhanced bone mineralization |
| 03/25/2004 | CA2498723A1 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | CA2498581A1 Thioredoxin composition and uses thereof for liquefaction of mucus or sputum |
| 03/25/2004 | CA2498548A1 Methods for treating lung cancer using insulin-like growth factor binding protein-3 |
| 03/25/2004 | CA2498525A1 Process for manufacturing crystals of growth hormone |
| 03/25/2004 | CA2498502A1 Recombinant clostridial toxin fragments with proteolytic activation |